Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Gimeracil/oteracil/tegafur

Lacrimal duct obstruction

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Bai F, et al. Clinical case analysis of severe lacrimal duct obstruction induced by tegafur-gimeracil-oteracil potassium. [Chinese]. Adverse drug reactions journal 22: 300-305, No. 5, 28 May 2020. Available from: URL: https://ywblfyzz.yiigle.com/?lang=En [Chinese; summarised from a translation] Bai F, et al. Clinical case analysis of severe lacrimal duct obstruction induced by tegafur-gimeracil-oteracil potassium. [Chinese]. Adverse drug reactions journal 22: 300-305, No. 5, 28 May 2020. Available from: URL: https://​ywblfyzz.​yiigle.​com/​?​lang=​En [Chinese; summarised from a translation]
Metadaten
Titel
Gimeracil/oteracil/tegafur
Lacrimal duct obstruction
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-56856-0

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Tozinameran

Case report

Ketamine

Case report

Pembrolizumab

Case report

Obinutuzumab

Case report

Multiple drugs